Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) vs NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
Side-by-side comparison of two grants.
| Attribute | Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) | NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) |
|---|---|---|
| Type | Grant | Grant |
| Funding amount | $6.3M | — |
| Deadline | Closes 2027-11-15 | Closes 2026-11-13 |
| Region | US | US |
| Sector | Health | Health |
| Funder | National Institutes of Health | National Institutes of Health |
| Who it's for | small-business, researchers, government | researchers, students, government |